Similarly, CDC7 (essential for the G1/S transition and initiation of DNA replication) and MAP3K8 (which activates MAPK and JNK) have not been validated as therapeutic targets in ccRCC and warrant further study. The gene discussed is MAPK8; the disease is nonpapillary renal cell carcinoma.